Engineering Human Kidneys in the Lab: A Breakthrough in Regenerative Medicine

AbstractChronic kidney disease (CKD) is the condition that has affected a number of people globally with limited treatment options concentrating on dialysis and organ transplantation. Stem cell biology, tissue engineering, and organoid technology have been the sources of human kidney tissue that is functional and can be used in vitro. The paper explores the advances in lab-grown human kidneys and the parts of it that are made from iPSC-derived kidney organoids, bioprinting technologies, and the problems of vascularization and maturation. The paper goes on to discuss how these changes are playing a big part in the future of regenerative nephrology and also solving the problem of organ shortage around the world. Besides, we are also addressing the ethical, technical, and translational problems that need to be solved so that lab-grown kidneys can be easily come from the bench and used at the bedside. The generation of kidney organoids and models produced by bio printing is a big step in the history of regenerative medicine. The paper addresses several topics open in the field of kidney organoid culture, neural crest and placode interactions, and 3D bioprinting technologies. In this paper we are reviewing the molecular and developmental biology of the process of organoid formation and the bioprinting innovations integrating them and providing a comprehensive Helicopter overview of kidney regeneration strategies. This merging gives the reader an insight into the whole-organ engineering, patient-specific therapies, and drug screening opportunities and challenges in the future Keywords: Kidney organoids, regenerative medicine, stem cells, iPSC, tissue engineering, 3D bioprinting, nephrology.